Delivery Order SPE2DB22D3010-SPE2DB25FP3AC
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,545.48 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This is a firm fixed-price delivery order with an ultimate completion date of July 21, 2025, awarded on July 18, 2025, with no set-aside designation. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,425.90 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml vials. This competitively awarded, non-set-aside contract was issued on July 25, 2025, with an ultimate completion date of July 28, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order operates under a firm fixed-price structure, typical for...
- The Defense Logistics Agency awarded a $11,570.41 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) injectable medication. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by July 25, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December...
- The Defense Logistics Agency awarded a $7,556.52 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials, with performance completion targeted for July 21, 2025. This delivery order represents a firm fixed-price, non-set-aside competitive award executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,731.88 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This competitively awarded, firm fixed-price contract was issued on July 25, 2025, with an ultimate completion date of July 28, 2025, and represents a child delivery order under a larger contract vehicle. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials, with a ceiling value of $10,491.72. This competitively awarded, non-set-aside contract is structured as a firm fixed price delivery order and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $11,345.06 on July 22, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This firm fixed-price delivery order, with an ultimate completion date of July 23, 2025, represents a non-competitive set-aside contract and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $37,518.24 to AmerisourceBergen Drug Corp for Ozempic 1 mg/dose (4 mg/3 mL) 3 mL vials. This competitive award, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, reflects a firm fixed-price contract with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under a larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,452.93 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This contract, which was competitively awarded with no set-aside designation, features firm fixed pricing and is scheduled for completion by July 23, 2025. The award was made on July 22, 2025, with performance to take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $14,515.87 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 28, 2025, and represents a small, time-sensitive pharmaceutical procurement. The product will be delivered to AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, where the company operates as a major...
- SPE2DB22D3010Indefinite Delivery Contract
- SPE2DB22D3010-SPE2DB25FP3ACDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,111.07 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This firm fixed-price, non-set-aside contract was awarded on July 22, 2025, with an ultimate completion date of July 23, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. This delivery order represents a child contract issued under a larger indefinite delivery vehicle. This award falls under AmerisourceBergen's comprehensive Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a broad portfolio of pharmaceutical products and medical supplies to support military healthcare systems globally, including medications for diabetes management, neurological conditions, pain management, and other therapeutic domains. The delivery order for Ozempic—a diabetes medication—exemplifies the company's critical role in fulfilling federal medical procurement needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through competitive award mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.1k | 7/22/25 |